Cynata Therapeutics Limited (51S.STU) Q1 2026 Earnings

26FebConfirmed
Q1 2026
-0.01
0.33
0.66
0.99

Details

Expected EPS
N/A
Actual EPS
-0.006445266678
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Cynata Therapeutics Limited (51S.STU) has reported earnings of -0.006445266678 per share for Q1 2026.

0 Comments

Share your thoughts